Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





New Biosensor Detects COVID-19 and SARS-CoV-2 Variants on People's Breath within a Minute

By HospiMedica International staff writers
Posted on 09 Jul 2021
An instant COVID-19 sensor could help transform day-to-day management of the pandemic, protecting frontline workers and the wider community.

RMIT University (Melbourne, Australia) is collaborating with partners including Soterius Pty Ltd. More...
(Melbourne, Australia) on the biosensor, which can detect the presence of tiny amounts of the SARS-CoV-2 virus and its variants. The sensor harnesses nanotechnology-enabled biosensors developed by RMIT researchers at its leading-edge Micro Nano Research Facility. The biosensors technology is covered in a patent application filed by RMIT, with the integrated system the subject of a patent application subsequently filed by Soterius. The successful prototype is now being further developed by Soterius in partnership with RMIT towards commercial release early 2022. The technology will initially be delivered to hospitals, with future applications in other essential worker and high-traffic settings including aged care, quarantine hotels, airports and schools.

Reliable, accurate and non-invasive, the Soterius Scout sensor can deliver results within a minute to provide the all-clear for someone to enter their work environment or alert them if they need to undertake a medical COVID test and self-isolate. Prototype tests conducted at RMIT have revealed that the Soterius Scout biosensor detects SARS-CoV-2 spike protein fragments with impressive accuracy and no false positives. The technology can detect COVID-19 even if someone is asymptomatic. Trials also show the sensor has potential to become a top performing diagnostic tool for respiratory illnesses and it is now being scaled to detect other diseases such as influenza and MERS.

“Our biosensor is so small it can fit on a personal fob card and it’s easy to use – you just need to swipe your card over a reader at checkpoints,” said Soterius co-founder Dr Alasdair Wood. “Importantly, one sensor can detect up to 8 viral strains and our technology can be easily adapted to detect new variants or novel viruses as they emerge. We hope the Soterius Scout biosensor could be a vital tool for managing COVID-19, providing accurate early detection to prevent outbreaks and avoid the need for future lockdowns.”

Related Links:
RMIT University
Soterius Pty Ltd.



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.